Regulatory T cells and rheumatic diseases

被引：0
作者：
Humrich, J. Y. [1 ]
Kamradt, T. [2 ]
Riemekasten, G. [1 ]
机构：
[1] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-10117 Berlin, Germany
[2] Univ Klinikum Jena, Inst Immunol, Jena, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2015年 / 74卷 / 01期
关键词：
Tolerance; Autoimmunity; Pathogenesis; Immunotherapy; Immunology; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERLEUKIN-2;
D O I：
10.1007/s00393-014-1446-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Regulatory T cells (Treg) are crucial for the maintenance of immunological peripheral tolerance by controlling the activation and expansion of autoreactive cells; therefore, they make a decisive contribution to the prevention and control of autoimmune diseases. The aims of this article are to summarize the history and role of Treg in science and medicine, to provide a brief introduction to the development and function, to explain how failures in Treg biology contribute to the development of autoimmune disease, to explain their specific role in particular rheumatic diseases and to provide an introduction to the therapeutic use of Treg in autoimmune diseases. Relevant original literature and review articles were analyzed and the results are summarized in this article. Disorders in Treg biology can contribute to the development of rheumatic diseases in various ways. In addition, their capability to suppress autoimmunity renders Treg an attractive target for the treatment of rheumatic diseases. The concept of Treg-mediated immunoregulation has evolved into an independent field of research in immunology and medicine. First translational approaches and clinical studies confirmed the therapeutic efficacy of Treg in the treatment of autoimmune syndromes.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 11 条
[1]   Treg Cells in Rheumatoid Arthritis: An Update [J].
Cooles, Faye A. H. ;
Isaacs, John D. ;
Anderson, Amy E. .
CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (09)
[2]   Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis [J].
Cutolo, Maurizio .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) :473-475
[3]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[4]   A function for interleukin 2 in Foxp3-expressing regulatory T cells [J].
Fontenot, JD ;
Rasmussen, JP ;
Gavin, MA ;
Rudensky, AY .
NATURE IMMUNOLOGY, 2005, 6 (11) :1142-1151
[5]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[6]  
GERSHON RK, 1970, IMMUNOLOGY, V18, P723
[7]   Interleukin 2 and systemic lupus erythematosus Beyond the transcriptional regulatory net abnormalities [J].
Gomez-Martin, Diana ;
Diaz-Zamudio, Mariana ;
Crispin, Jose Carlos ;
Alcocer-Varela, Jorge .
AUTOIMMUNITY REVIEWS, 2009, 9 (01) :34-39
[8]   IMMUNOREGULATORY T-CELL PATHWAYS [J].
GREEN, DR ;
FLOOD, PM ;
GERSHON, RK .
ANNUAL REVIEW OF IMMUNOLOGY, 1983, 1 :439-463
[9]   Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? [J].
Huehn, Jochen ;
Polansky, Julia K. ;
Hamann, Alf .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (02) :83-89
[10]   Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease [J].
Koreth, John ;
Matsuoka, Ken-ichi ;
Kim, Haesook T. ;
McDonough, Sean M. ;
Bindra, Bhavjot ;
Alyea, Edwin P., III ;
Armand, Philippe ;
Cutler, Corey ;
Ho, Vincent T. ;
Treister, Nathaniel S. ;
Bienfang, Don C. ;
Prasad, Sashank ;
Tzachanis, Dmitrios ;
Joyce, Robin M. ;
Avigan, David E. ;
Antin, Joseph H. ;
Ritz, Jerome ;
Soiffer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22) :2055-2066
12